Acarbose: Package Insert and Label Information (Page 3 of 3)

HOW SUPPLIED

Acarbose Tablets, USP are supplied as follows:

For 25 mg: White to off white, round, biconvex tablets, debossed with “HP” on one side and “147” on other side.

For 50 mg: White to off white, round, biconvex tablets, debossed with “HP” and “148” on one side and plain on other side.

For 100 mg: White to off white, round, biconvex tablets, debossed with “HP” and “149” on one side and plain on other side.

Acarbose Tablets, USP 25 mg/50 mg/100 mg are available in Bottles of 100, 500 & 1,000.

Strength NDC Table t Identificatio n
Bottles of 100 with child-resistance closure Bottles of 500 with child-resistance closure Bottles of 1,000 with child-resistance closure 25 mg 25 mg 25 mg23155-147-01 23155-147-05 23155-147-10“HP” on one side and “147” on other side.
Bottles of 100 with child-resistance closure Bottles of 500 with child-resistance closure Bottles of 1,000 with child-resistance closure 50 mg 50 mg 50 mg23155-148-01 23155-148-05 23155-148-10“HP” and “148” on one side and plain on other side.
Bottles of 100 with child-resistance closure Bottles of 500 with child-resistance closure Bottles of 1,000 with child-resistance closure 100 mg 100 mg 100 mg23155-149-01 23155-149-05 23155-149-10“HP” and “149” on one side and plain on other side.

Store at 20o to 25o C (68o to 77o F) [see USP Controlled Room Temperature]. Protect from moisture. For bottles, keep container tightly closed.

Manufactured by:

RA CHEM PHARMA LIMITED

Hyderabad – 500 076, INDIA

Distributed by:

Avet Pharmaceuticals Inc.

East Brunswick, NJ 08816

1.866.901.DRUG (3784)

Avet logo
(click image for full-size original)

Revised: 01/2020

OR

Distributed by:
Avet Pharmaceuticals Inc.
East Brunswick, NJ 088161.866.901.DRUG(3784)

Avet logo new
(click image for full-size original)

40211

Revised: 06/2022

PACKAGE LABEL PRINCIPAL DISPLAY PANEL (25mg)

NDC 23155-147 -01

Acarbose Tablets, USP

25 mg

100 Tablets

Rx only

25 mg label
(click image for full-size original)
25 mg
(click image for full-size original)

PACKAGE LABEL PRINCIPAL DISPLAY PANEL (50mg)

NDC 23155-148 -01

Acarbose Tablets, USP

50 mg

100 Tablets

Rx only

50 mg label revised
(click image for full-size original)

50 mg label
(click image for full-size original)

PACKAGE LABEL PRINCIPAL DISPLAY PANEL (100mg)

NDC 23155-149 -01

Acarbose Tablets, USP

100 mg

100 Tablets

Rx only

100 mg revised
(click image for full-size original)
100 mg label
(click image for full-size original)
ACARBOSE acarbose tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:23155-147
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ACARBOSE (ACARBOSE) ACARBOSE 25 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
MICROCRYSTALLINE CELLULOSE
SILICON DIOXIDE
MAGNESIUM STEARATE
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 6mm
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:23155-147-05 500 TABLET in 1 BOTTLE None
2 NDC:23155-147-01 100 TABLET in 1 BOTTLE None
3 NDC:23155-147-10 1000 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA202271 04/16/2021
ACARBOSE acarbose tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:23155-148
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ACARBOSE (ACARBOSE) ACARBOSE 50 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
MICROCRYSTALLINE CELLULOSE
SILICON DIOXIDE
MAGNESIUM STEARATE
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 7mm
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:23155-148-05 500 TABLET in 1 BOTTLE None
2 NDC:23155-148-01 100 TABLET in 1 BOTTLE None
3 NDC:23155-148-10 1000 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA202271 04/16/2021
ACARBOSE acarbose tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:23155-149
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ACARBOSE (ACARBOSE) ACARBOSE 100 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
MICROCRYSTALLINE CELLULOSE
SILICON DIOXIDE
MAGNESIUM STEARATE
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 9mm
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:23155-149-01 100 TABLET in 1 BOTTLE None
2 NDC:23155-149-05 500 TABLET in 1 BOTTLE None
3 NDC:23155-149-10 1000 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA202271 04/16/2021
Labeler — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (780779901)
Registrant — AVET LIFESCIENCES PRIVATE LIMITED (853181664)
Establishment
Name Address ID/FEI Operations
RA CHEM PHARMA LIMITED 677637710 MANUFACTURE (23155-147), MANUFACTURE (23155-148), MANUFACTURE (23155-149)
Establishment
Name Address ID/FEI Operations
CorePharma, LLC 031192276 manufacture (23155-147), manufacture (23155-148), manufacture (23155-149)

Revised: 03/2023 Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Page 3 of 3 1 2 3

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.